A simple, specific, and sensitive high-performance liquid chromatography method has been developed for simultaneous determination of the lomefloxacin, febufen, and felbinac in human plasma. Plasma-spiked with internal standard, was vortex-mixed for 1 min with a mixture of dichloromethane-diethylether (80:20, v/v). The evaporated extract was dissolved in 0.02 M NaOH. The extracts were chromatographed on an Supelcosil LCSAX column (5 μm 250×4.6 mm I.D.) equipped with a guard column with a mibile phase composed of acetonitrile and phosphate buffer, with ultraviolet detection. Drugs were resolved at ambient temperature on a flow rate was 1.2 mL min−1, and monitoring was performed at 280 nm. The detection limits for lomefloxacin was 0.05 μg mL−1, 0.02 μg mL−1 for fenbufen and 0.03 μg mL−1 for felbinac. No interference from other commonly administered drugs or endogenous substances was observed. The method is fast since it involves two extraction steps followed by evaporation of organic solvent and chromatography of the residue. This method was found to be applicable to pharmacokinetic and pharmacodynamic studies of each drug after the concomitant administration of lomefloxacin and febufen.

Simultaneous determination of lomefloxacin, fenbufen and felbinac in human plasma using high performance liquid chromatography

CARLUCCI, Giuseppe;MAZZEO, PIETRO;
1996-01-01

Abstract

A simple, specific, and sensitive high-performance liquid chromatography method has been developed for simultaneous determination of the lomefloxacin, febufen, and felbinac in human plasma. Plasma-spiked with internal standard, was vortex-mixed for 1 min with a mixture of dichloromethane-diethylether (80:20, v/v). The evaporated extract was dissolved in 0.02 M NaOH. The extracts were chromatographed on an Supelcosil LCSAX column (5 μm 250×4.6 mm I.D.) equipped with a guard column with a mibile phase composed of acetonitrile and phosphate buffer, with ultraviolet detection. Drugs were resolved at ambient temperature on a flow rate was 1.2 mL min−1, and monitoring was performed at 280 nm. The detection limits for lomefloxacin was 0.05 μg mL−1, 0.02 μg mL−1 for fenbufen and 0.03 μg mL−1 for felbinac. No interference from other commonly administered drugs or endogenous substances was observed. The method is fast since it involves two extraction steps followed by evaporation of organic solvent and chromatography of the residue. This method was found to be applicable to pharmacokinetic and pharmacodynamic studies of each drug after the concomitant administration of lomefloxacin and febufen.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/453090
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact